Chronic liver disease is on the rise1 which can progress to Hepatocellular Carcinoma (HCC), a type of liver cancer2. What are the risk factors for HCC and how is it diagnosed and treated?
References:
- Moon Am, et al. Clin Gastroenterol Hepatol. 2019 Aug
- Omata et al. APASL guideline Hepatol Int (2017) 11:317–370
- WHO: Globocan 2018 – Liver cancer factsheet. [Internet; cited 2019 July 24] Available from: http://gco.iarc.fr/today/data/factsheets/cancers/11-Liver-fact-sheet.pdf.
- Llovet J, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018.
- WHO: Globocan 2018 – China cancer factsheet. [Internet; cited 2019 July 24] Available from: http://gco.iarc.fr/today/data/factsheets/populations/160-china-fact-sheets.pdf.
- Tanaka M, et al. Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures. J Epidemiol. 2011;21(6):401-416.
- Medline. [Internet; cited 2019 July 24]. Available from: https://medlineplus.gov/ency/article/000280.htm.
- Giannini G, et al. Prognosis of untreated hepatocellular carcinoma. Hepatology. 2015;61(1):184-190.
- Medscape. [Internet; cited 2019 July 24]. Available from: https://emedicine.medscape.com/article/369226-overview.
- Omata et al. APASL guideline Hepatol Int (2017_ 11:317-370)
- World Health Organization. The top 10 causes of death in 2015. WHO http://www.who.int/mediacentre/factsheets/fs310/en/index1.html (2016).
- Wu Q, Qin S. Features and treatment options of Chinese hepatocellular Carcinoma. Chin Clin Oncol. 2013;2(4):38.
- Marrero K, Kulik L, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723-750.
- Zhao et al. Liver International 2018; 38: 503-514
